HK1045119A1 - 用於治療癌症的放射性順鉑 - Google Patents

用於治療癌症的放射性順鉑

Info

Publication number
HK1045119A1
HK1045119A1 HK02106701.5A HK02106701A HK1045119A1 HK 1045119 A1 HK1045119 A1 HK 1045119A1 HK 02106701 A HK02106701 A HK 02106701A HK 1045119 A1 HK1045119 A1 HK 1045119A1
Authority
HK
Hong Kong
Prior art keywords
cancer
treatment
cisplatin
radioactive
radioactive cisplatin
Prior art date
Application number
HK02106701.5A
Other languages
English (en)
Inventor
斯坦利‧E‧奧德
Original Assignee
同位素方案解決公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 同位素方案解決公司 filed Critical 同位素方案解決公司
Publication of HK1045119A1 publication Critical patent/HK1045119A1/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Physics & Mathematics (AREA)
  • Optics & Photonics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
HK02106701.5A 1999-03-19 2002-09-13 用於治療癌症的放射性順鉑 HK1045119A1 (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/272,549 US6074626A (en) 1998-03-20 1999-03-19 Radioactive cisplatin in the treatment of cancer
PCT/US2000/006546 WO2000056369A1 (en) 1999-03-19 2000-03-14 Radioactive cisplatin in the treatment of cancer

Publications (1)

Publication Number Publication Date
HK1045119A1 true HK1045119A1 (zh) 2002-11-15

Family

ID=23040266

Family Applications (1)

Application Number Title Priority Date Filing Date
HK02106701.5A HK1045119A1 (zh) 1999-03-19 2002-09-13 用於治療癌症的放射性順鉑

Country Status (15)

Country Link
US (1) US6074626A (zh)
EP (1) EP1176988B1 (zh)
JP (1) JP2003512296A (zh)
KR (1) KR20010108357A (zh)
AU (1) AU782093B2 (zh)
CZ (1) CZ20013216A3 (zh)
HK (1) HK1045119A1 (zh)
HU (1) HUP0200717A3 (zh)
IL (1) IL145149A0 (zh)
MX (1) MXPA01009458A (zh)
NO (1) NO20014228L (zh)
NZ (1) NZ513872A (zh)
TR (1) TR200102576T2 (zh)
WO (1) WO2000056369A1 (zh)
ZA (1) ZA200107312B (zh)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPQ641100A0 (en) * 2000-03-23 2000-04-15 Australia Nuclear Science & Technology Organisation Methods of synthesis and use of radiolabelled platinum chemotherapeutic ag ents
US20030082102A1 (en) * 2001-06-25 2003-05-01 Court Wayne S. Radioactive platinum complexes for cancer treatment
JP2005510471A (ja) * 2001-09-24 2005-04-21 トスク インコーポレーティッド 減少した毒性のシスプラチン製剤及びそれを使用する方法
US20030228253A1 (en) * 2002-06-06 2003-12-11 Aranoff Shraga D. Radiolabelled thioplatin, compositions thereof and methods of cancer treatment
US6751280B2 (en) * 2002-08-12 2004-06-15 Ut-Battelle, Llc Method of preparing high specific activity platinum-195m
US20060052690A1 (en) * 2004-09-08 2006-03-09 Sirohey Saad A Contrast agent imaging-driven health care system and method
US20100035853A1 (en) * 2008-08-07 2010-02-11 Hyogo College Of Medicine Method for preventing or treating cisplatin-induced nephrotoxicity

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4302446A (en) * 1979-10-02 1981-11-24 Bristol-Myers Company Pharmaceutical compositions
US4451447A (en) * 1980-03-31 1984-05-29 Bristol-Myers Company Pharmaceutical formulations
US4536386B1 (en) * 1981-01-26 1995-03-07 Robins Co Inc A H Method of controlling emesis caused by cisplatin in cancer chemotherapy
IL83380A (en) * 1987-07-30 1991-04-15 Teva Pharma Stable aqueous cisplatin solutions
ZA885929B (en) * 1987-08-25 1989-04-26 Oxi Gene Inc Agents for use in tumor or cancer cell killing therapy
US5844001A (en) * 1993-02-26 1998-12-01 Research Development Foundation Combination platinum chemotherapeutic/antiestrogen therapy for human cancers
US5484612A (en) * 1993-09-22 1996-01-16 The Board Of Trustees Of The Leland Stanford Junior University Method of treating a mammal having a solid tumor susceptible to treatment with cisplatin

Also Published As

Publication number Publication date
NZ513872A (en) 2003-08-29
EP1176988A4 (en) 2003-04-23
CZ20013216A3 (cs) 2002-01-16
EP1176988A1 (en) 2002-02-06
AU4009400A (en) 2000-10-09
TR200102576T2 (tr) 2002-06-21
US6074626A (en) 2000-06-13
HUP0200717A2 (hu) 2002-07-29
NO20014228D0 (no) 2001-08-31
NO20014228L (no) 2001-08-31
JP2003512296A (ja) 2003-04-02
EP1176988B1 (en) 2004-11-24
IL145149A0 (en) 2002-06-30
ZA200107312B (en) 2002-05-22
KR20010108357A (ko) 2001-12-07
WO2000056369A1 (en) 2000-09-28
AU782093B2 (en) 2005-06-30
MXPA01009458A (es) 2004-10-14
HUP0200717A3 (en) 2004-11-29

Similar Documents

Publication Publication Date Title
PL370029A1 (en) 2-amino-4-heteroarylaminopyrimidine derivatives for use in the treatment of cancer
GB9912411D0 (en) Compounds useful in therapy
IL148579A0 (en) Oncolytic combinations for the treatment of cancer
IL136167A0 (en) Conjugates useful in the treatment of prostate cancer
GB9912410D0 (en) Compounds useful in therapy
HUP0300339A3 (en) Use of fulvestrant in the treatment of resistant breast cancer
IL145149A0 (en) Radioactive cisplatin in the treatment of cancer
IL149281A0 (en) Treatment of cancer
GB0026015D0 (en) Cancer treatment
ZA9810974B (en) Conjugates useful in the treatment of prostate cancer
PL349955A1 (en) Radioactive cisplatin in the treatment of cancer
GB9804361D0 (en) Cancer treatment
GB9903035D0 (en) Treating cancer
GB9927106D0 (en) Cancer treatment
GB9908176D0 (en) Cancer treatment
GB2334579B (en) Treating cancer
GB9820000D0 (en) Cancer treatment
GB9818023D0 (en) Cancer treatment
GB9911302D0 (en) Treating cancer
GB0007254D0 (en) Treating cancer
GB9815855D0 (en) Conjugates useful in the treatment of prostate cancer
GB9810183D0 (en) Conjugates useful in the treatment of prostate cancer
GB9804399D0 (en) Conjugates useful in the treatment of prostate cancer
HK1034979A1 (en) Conjugates useful in the treatment of prostate cancer.
SI1165537T1 (en) Hydroxymatairesinol in cancer prevention